Features of the Functional State of the Hypophysis-Ovarian System and Processes of Lipid Peroxidation – Antioxidant Protection in Women with Hyperandrogenism of Ovary Genesis in the Early Reproductive Period

Background. Women with polycystic ovary syndrome in the early reproductive period have hormonal and metabolic dysfunction and an increased risk of long-term health consequences. The article presents the results of the study of hormonal indicators and the parameters of lipid peroxidation – antioxidant protection in women  with polycystic ovary syndrome in early period of reproductive age (from 18 to 35 years old).

Aim: evaluation of the functional state of the pituitary-ovarian-adrenal system and the lipid peroxidation – antioxidant protection system and the establishment of intersystemic relationships in women of the early reproductive period with polycystic ovary syndrome.

Materials and methods. Study included 33 women with ovarian hyperandrogenism and 17 healthy women of early reproductive age. A questionnaire survey, general medical and gynecological examinations, and ultrasound examination of the pelvic organs were conducted. Immunoenzyme method for detection the concentration of hormones, spectrophotometric and spectrofluorometric (determination of the concentration of  lipoperoxidation products, parameters of antioxidant protection), statistical methods were used.

Results. Women of early reproductive age (from 18 to 35 years old) with polycystic ovary syndrome characterized by an increase of 17-OH-progesterone by 2.2 times (p = 0.0005), and dehydroepiandrosterone sulfate by 1.3 times (p = 0.0001). A decrease in the total antioxidant activity of the blood by 25 % (p = 0.0005), an increase in the content of oxidized glutathione by 14 % (p = 0.0001) and a decrease in the concentration of retinol by 26 % (p = 0.0012) compared to the control values were shown. The increase in the  degree of oxidative stress was indicated by the value of the coefficient of oxidative stress equal to 2.8.

Conclusion. The obtained data indicate the features of the functional state of the pituitary-ovarian-adrenal system and the processes of LPO–AOP, as well as the need for timely diagnosis and effective correction of hormonal and metabolic disorders in women with polycystic ovary syndrome in the early reproductive period.

1. Walker W, Lizneva DV, Belenkaia LV, Lazareva LM, Suturina LV. Criteria, phenotypes and prevalence of polycystic ovary syndrome. Minerva Ginecol. 2019; 71(3): 211-223. doi: 10.23736/S0026-4784.19.04404-6

2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004; 89(6): 2745-2749. doi: 10.1210/jc.2003-032046

3. Suturina LV. Polycystic ovary syndrome in the 21st century.Akusherstvo i ginekologiya: novosti, mneniya, obuchenie. 2017; 3(17): 86-91. doi: 10.24411/2303-9698-2017-00040 (In Russ.)

4. Anagnostis P, Tarlatzis BC, Kauffman RP. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. Metabolism. 2018; 86: 33-43. doi: 10.1016/j.metabol.2017.09.016

5. Barber TM, Dimitriadis GK, Andreou A, Franks S. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance. Clin Med (Lond). 2016; 16(3): 262-266. doi: 10.7861/clinmedicine.15-6-s72

6. De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016; 14(38): 1-17. doi: 10.1186/s12958-016-0173-x

7. González F, Rote NS, Minium J, Kirwan JP. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006; 91(1): 336-340. doi: 10.1210/jc.2005-1696

8. Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015; 97: 55-74. doi: 10.1016/j.ejmech.2015.04.040

9. Ramana KV, Srivastava S, Singhal SS. Lipid peroxidation products in human health and disease 2016. Oxid Med Cell Longev. 2017; 2017: 2163285. doi: 10.1155/2017/2163285

10. Kolesnikova LI, Darenskaya MA, Kolesnikov SI. Free radical oxidation: a pathophysiologist’s view. Byulleten sibirskoj mediciny. 2017; 16(4): 16-29. doi: 10.20538/1682-0363-2017-4-16–29 (In Russ.)

11. Semyonova N.V. Oxidative stress and menopause (review of literature). Acta biomedica scientifica. 2014; (2): 120-125. (In Russ.)

12. Sharma RK, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Review article. Reprod Med Biol. 2004; 3(4): 177-199. doi: 10.1111/j.1447-0578.2004.00068.x

13. Siti HN, Kamisah Y, Kamsiah J. The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol. 2015; 71: 40-56. doi: 10.1016/j.vph.2015.03.005

14. Chandrasekaran A, Idelchik MDPS, Melendez JA. Redox control of senescence and age-related disease. Redox Biol. 2017; 11: 91-102. doi: 10.1016/j.redox.2016.11.005

15. Semenova NV, Madaeva IM, Darenskaya MA, Kolesnikova LI. Lipid peroxidation and antioxidant defense system in menopausal women of different ethnic groups. Human Ecology. 2019; (6): 30-38. doi: 10.33396/1728-0869-2019-6-30-38 (In Russ.)

16. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004; 19(1): 41-47. doi: 10.1093/humrep/deh098

17. Volchegorskiy IA, Nalimov AG, Yarovinskiy BG, Lifshits RI. Comparison of different approaches to the determination of lipid peroxidation products in heptane-isopropanol blood extracts. Voprosy meditsinskoy khimii. 1989; 35(1): 127-131. (In Russ.)

18. Gavrilov VB, Gavrilova AR, Magul LM. Analysis of the methods of determination of lipid peroxidation products in blood serum by the test with thiobarbituric acid. Voprosy meditsinskoy khimii. 1987; 33(1): 118-122. (In Russ.)

19. Chernyauskene RCh, Varshkyavichene ZZ, Gribauskas PS. Simultaneous determination of vitamins E and A in blood serum. Laboratornoe delo. 1984; (6): 362-365. (In Russ.)

20. Hissin PJ, Hilf R. Fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976; 74(1): 214-226. doi: 10.1016/0003-2697(76)90326-2

21. Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972; 247(10): 3170-3175.

22. Vorokhobina NV, Tatarinova MV, Velikanova LI, Serebryakova IP, Malevanaya EV, Galahova RK. Features of steroid hormone metabolism in fertile age females with various forms of hyperandrogenism. Herald of North-Western State Medical University named after I.I. Mechnikov. 2016; 8(3): 42-49. (In Russ.)

23. Manukhin IB, Gevorkyan MA, Minkina GN, Manukhina EI, Bakhis H. Recovery of reproductive function in patients with suprarenal hyperandrogenia. Voprosy ginekologii, akusherstva i perinatologii. 2004; 3(6): 7-11. (In Russ.)

24. Kolesnikova LI, Grebenkina LA, Darenskaya MA, Vlasov BYa. Oxidative stress as nonspecific pathogenetic link of reproductive disorders (systematic review). Sibirskij nauchnyj medicinskij zhurnal. 2012; 32(1): 58-66. (In Russ.)

25. Zuo T, Zhu M, Xu W. Roles of oxidative stress in polycystic ovary syndrome and cancers. Oxid Med Cell Longev. 2016; 1-14. doi: 10.1155/2016/8589318

26. Kolesnikova LI, Kornakova NV, Labigina AV, Petrova VA, Sholokhov LF, Dolgih MI, et al. Hormonal-metabolic processes condition of women with polycystic ovaries and infertility. Byulleten SO RAMN. 2008; 28(1): 21-25. (In Russ.)

27. Kolesnikova LI, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Nikitina OA, Lazareva LM, et al. Activity of LPO processes in women with polycystic ovarian syndrome and infertility. Bulletin of Experimental Biology and Medicine. 2017; 162(3): 320-322. doi: 10.1007/s10517-017-3605-5